APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nystatin Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nystatin Tablets Market Outlook and Growth Opportunities 2026

29 December 2025194 pages

Choose your research edition.

Industry ResearchNystatin Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Nystatin Tablets Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Nystatin Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nystatin Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nystatin Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Nystatin Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nystatin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nystatin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nystatin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nystatin Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nystatin Tablets market include Yunpeng Pharmaceutical Group, Teva Pharmaceuticals, Shandong Lukang Pharmaceutical, Avet Pharmaceuticals and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nystatin Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nystatin Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nystatin Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nystatin Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Nystatin Tablets Segment by Company

Yunpeng Pharmaceutical Group

Teva Pharmaceuticals

Shandong Lukang Pharmaceutical

Avet Pharmaceuticals

AdvaCare Pharma

Nystatin Tablets Segment by Type

Original Drug

Generic Drug

Nystatin Tablets Segment by Application

Hospital

Clinic

Others

Nystatin Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nystatin Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nystatin Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nystatin Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Nystatin Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nystatin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nystatin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nystatin Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nystatin Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nystatin Tablets industry.

Chapter 3: Detailed analysis of Nystatin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nystatin Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nystatin Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nystatin Tablets Industry Trends Table 2. Nystatin Tablets Industry Drivers Table 3. Nystatin Tablets Industry Opportunities and Challenges Table 4. Nystatin Tablets Industry Restraints Table 5. Global Nystatin Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nystatin Tablets Revenue Share by Company (2021-2026) Table 7. Global Nystatin Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nystatin Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Nystatin Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nystatin Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nystatin Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Nystatin Tablets Company, Product Type & Application Table 13. Global Nystatin Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nystatin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Nystatin Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nystatin Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Nystatin Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Nystatin Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Nystatin Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Nystatin Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nystatin Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nystatin Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nystatin Tablets Sales Value Share by Type (2021-2026) Table 28. Global Nystatin Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Nystatin Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Nystatin Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Nystatin Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Nystatin Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Nystatin Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Nystatin Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nystatin Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Nystatin Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Nystatin Tablets Sales Value Share by Application (2021-2026) Table 41. Global Nystatin Tablets Sales Value Share by Application (2027-2032) Table 42. Global Nystatin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Nystatin Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Nystatin Tablets Sales Market Share by Region (2021-2026) Table 45. Global Nystatin Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Nystatin Tablets Sales Market Share by Region (2027-2032) Table 47. Global Nystatin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nystatin Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Nystatin Tablets Sales Value Share by Region (2021-2026) Table 50. Global Nystatin Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Nystatin Tablets Sales Value Share by Region (2027-2032) Table 52. Global Nystatin Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Nystatin Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Nystatin Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Nystatin Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Nystatin Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Nystatin Tablets Sales Market Share by Country (2021-2026) Table 58. Global Nystatin Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Nystatin Tablets Sales Market Share by Country (2027-2032) Table 60. Global Nystatin Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Nystatin Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Nystatin Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Nystatin Tablets Sales Value Market Share by Country (2027-2032) Table 64. Yunpeng Pharmaceutical Group Company Information Table 65. Yunpeng Pharmaceutical Group Business Overview Table 66. Yunpeng Pharmaceutical Group Nystatin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yunpeng Pharmaceutical Group Nystatin Tablets Product Portfolio Table 68. Yunpeng Pharmaceutical Group Recent Development Table 69. Teva Pharmaceuticals Company Information Table 70. Teva Pharmaceuticals Business Overview Table 71. Teva Pharmaceuticals Nystatin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Teva Pharmaceuticals Nystatin Tablets Product Portfolio Table 73. Teva Pharmaceuticals Recent Development Table 74. Shandong Lukang Pharmaceutical Company Information Table 75. Shandong Lukang Pharmaceutical Business Overview Table 76. Shandong Lukang Pharmaceutical Nystatin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shandong Lukang Pharmaceutical Nystatin Tablets Product Portfolio Table 78. Shandong Lukang Pharmaceutical Recent Development Table 79. Avet Pharmaceuticals Company Information Table 80. Avet Pharmaceuticals Business Overview Table 81. Avet Pharmaceuticals Nystatin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Avet Pharmaceuticals Nystatin Tablets Product Portfolio Table 83. Avet Pharmaceuticals Recent Development Table 84. AdvaCare Pharma Company Information Table 85. AdvaCare Pharma Business Overview Table 86. AdvaCare Pharma Nystatin Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AdvaCare Pharma Nystatin Tablets Product Portfolio Table 88. AdvaCare Pharma Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Nystatin Tablets Distributors List Table 92. Nystatin Tablets Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Nystatin Tablets Product Image Figure 2. Global Nystatin Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nystatin Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nystatin Tablets Sales (2021-2032) & (K Units) Figure 5. Global Nystatin Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nystatin Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Nystatin Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Nystatin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nystatin Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Nystatin Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nystatin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nystatin Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Nystatin Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Nystatin Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Nystatin Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Nystatin Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nystatin Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Nystatin Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Nystatin Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Nystatin Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Nystatin Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Nystatin Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Nystatin Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Nystatin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Nystatin Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Nystatin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Nystatin Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Nystatin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Nystatin Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Nystatin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Nystatin Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Nystatin Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Nystatin Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Nystatin Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Nystatin Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Nystatin Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Nystatin Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Yunpeng Pharmaceutical Group
  • Teva Pharmaceuticals
  • Shandong Lukang Pharmaceutical
  • Avet Pharmaceuticals
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nystatin Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Nystatin Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Nystatin Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nystatin Tablets Market Dynamics
  1. 2.1 Nystatin Tablets Industry Trends
  2. 2.2 Nystatin Tablets Industry Drivers
  3. 2.3 Nystatin Tablets Industry Opportunities and Challenges
  4. 2.4 Nystatin Tablets Industry Restraints
3 Nystatin Tablets Market by Company
  1. 3.1 Global Nystatin Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Nystatin Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Nystatin Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Nystatin Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Nystatin Tablets Company Ranking (2024-2026)
  6. 3.6 Global Nystatin Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Nystatin Tablets Company Product Type and Application
  8. 3.8 Global Nystatin Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nystatin Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nystatin Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nystatin Tablets Market by Type
  1. 4.1 Nystatin Tablets Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Nystatin Tablets Sales Volume by Type
  5. 4.2.1 Global Nystatin Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nystatin Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nystatin Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nystatin Tablets Sales Value by Type
  9. 4.3.1 Global Nystatin Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nystatin Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nystatin Tablets Sales Value Share by Type (2021-2032)
5 Nystatin Tablets Market by Application
  1. 5.1 Nystatin Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Nystatin Tablets Sales Volume by Application
  6. 5.2.1 Global Nystatin Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nystatin Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nystatin Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nystatin Tablets Sales Value by Application
  10. 5.3.1 Global Nystatin Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nystatin Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nystatin Tablets Sales Value Share by Application (2021-2032)
6 Nystatin Tablets Regional Sales and Value Analysis
  1. 6.1 Global Nystatin Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nystatin Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Nystatin Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Nystatin Tablets Sales by Region (2027-2032)
  5. 6.3 Global Nystatin Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nystatin Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nystatin Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nystatin Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Nystatin Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nystatin Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Nystatin Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nystatin Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Nystatin Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nystatin Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nystatin Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nystatin Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Nystatin Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nystatin Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nystatin Tablets Sales Value Share by Country, 2025 VS 2032
7 Nystatin Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Nystatin Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nystatin Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nystatin Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Nystatin Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Nystatin Tablets Sales by Country (2027-2032)
  6. 7.4 Global Nystatin Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nystatin Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nystatin Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nystatin Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nystatin Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nystatin Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nystatin Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nystatin Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nystatin Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nystatin Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nystatin Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nystatin Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nystatin Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nystatin Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nystatin Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nystatin Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nystatin Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nystatin Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nystatin Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nystatin Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nystatin Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nystatin Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nystatin Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nystatin Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nystatin Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nystatin Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nystatin Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nystatin Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nystatin Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nystatin Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nystatin Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nystatin Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nystatin Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunpeng Pharmaceutical Group
  2. 8.1.1 Yunpeng Pharmaceutical Group Company Information
  3. 8.1.2 Yunpeng Pharmaceutical Group Business Overview
  4. 8.1.3 Yunpeng Pharmaceutical Group Nystatin Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yunpeng Pharmaceutical Group Nystatin Tablets Product Portfolio
  6. 8.1.5 Yunpeng Pharmaceutical Group Recent Developments
  7. 8.2 Teva Pharmaceuticals
  8. 8.2.1 Teva Pharmaceuticals Company Information
  9. 8.2.2 Teva Pharmaceuticals Business Overview
  10. 8.2.3 Teva Pharmaceuticals Nystatin Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceuticals Nystatin Tablets Product Portfolio
  12. 8.2.5 Teva Pharmaceuticals Recent Developments
  13. 8.3 Shandong Lukang Pharmaceutical
  14. 8.3.1 Shandong Lukang Pharmaceutical Company Information
  15. 8.3.2 Shandong Lukang Pharmaceutical Business Overview
  16. 8.3.3 Shandong Lukang Pharmaceutical Nystatin Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lukang Pharmaceutical Nystatin Tablets Product Portfolio
  18. 8.3.5 Shandong Lukang Pharmaceutical Recent Developments
  19. 8.4 Avet Pharmaceuticals
  20. 8.4.1 Avet Pharmaceuticals Company Information
  21. 8.4.2 Avet Pharmaceuticals Business Overview
  22. 8.4.3 Avet Pharmaceuticals Nystatin Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Avet Pharmaceuticals Nystatin Tablets Product Portfolio
  24. 8.4.5 Avet Pharmaceuticals Recent Developments
  25. 8.5 AdvaCare Pharma
  26. 8.5.1 AdvaCare Pharma Company Information
  27. 8.5.2 AdvaCare Pharma Business Overview
  28. 8.5.3 AdvaCare Pharma Nystatin Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AdvaCare Pharma Nystatin Tablets Product Portfolio
  30. 8.5.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nystatin Tablets Value Chain Analysis
  2. 9.1.1 Nystatin Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nystatin Tablets Sales Mode & Process
  6. 9.2 Nystatin Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nystatin Tablets Distributors
  9. 9.2.3 Nystatin Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst